Lv6
2800 积分 2024-01-07 加入
Abstract A015: JAB-BX600, a first-in-class EGFR-directed antiboEdy drug conjugate delivering a novel KRAS G12D inhibitor
17小时前
待确认
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
2天前
已完结
Discovery and Characterization of RP03707: A Highly Potent and Selective KRASG12D PROTAC
3天前
已完结
Mass Spectrometry Reveals High Levels of Hydrogen Peroxide in Pancreatic Cancer Cells
4天前
已完结
Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers
4天前
已完结
An overview of KRAS G12D inhibitors: Expanding the therapeutic frontier of KRAS in targeting KRAS G12D using diverse therapeutic modalities
5天前
已完结
Emerging landscape of KRAS inhibitors in cancer treatment
9天前
已完结
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancer
11天前
已完结
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
12天前
已完结
SIL-204 siRNA encapsulated in extended release microparticles for the treatment of localized cancer that harbors a KRAS G12x or G13D mutation
12天前
已关闭
皖公网安备34019202002308
